Predictive Oncology Past Earnings Performance
Past criteria checks 0/6
Predictive Oncology's earnings have been declining at an average annual rate of -22.4%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 5% per year.
Key information
-22.4%
Earnings growth rate
52.2%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 5.0% |
Return on equity | -139.0% |
Net Margin | -1,802.4% |
Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Predictive Oncology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 1 | -26 | 16 | 0 |
31 Dec 22 | 2 | -26 | 16 | 0 |
30 Sep 22 | 2 | -26 | 16 | 0 |
30 Jun 22 | 1 | -27 | 15 | 0 |
31 Mar 22 | 1 | -19 | 14 | 0 |
31 Dec 21 | 1 | -20 | 14 | 0 |
30 Sep 21 | 1 | -23 | 13 | 0 |
30 Jun 21 | 1 | -25 | 13 | 0 |
31 Mar 21 | 1 | -26 | 14 | 0 |
31 Dec 20 | 1 | -26 | 13 | 0 |
30 Sep 20 | 1 | -29 | 13 | 0 |
30 Jun 20 | 1 | -26 | 14 | 0 |
31 Mar 20 | 1 | -21 | 15 | 0 |
31 Dec 19 | 1 | -20 | 14 | 0 |
30 Sep 19 | 1 | -9 | 15 | 0 |
30 Jun 19 | 1 | -8 | 13 | 0 |
31 Mar 19 | 1 | -12 | 9 | 0 |
31 Dec 18 | 1 | -10 | 9 | 0 |
30 Sep 18 | 1 | -8 | 7 | 0 |
30 Jun 18 | 1 | -6 | 6 | 0 |
31 Mar 18 | 1 | -6 | 7 | 0 |
31 Dec 17 | 1 | -6 | 7 | 0 |
30 Sep 17 | 1 | -6 | 6 | 0 |
30 Jun 17 | 1 | -6 | 6 | 0 |
31 Mar 17 | 1 | -6 | 5 | 0 |
31 Dec 16 | 0 | -7 | 6 | 0 |
30 Sep 16 | 1 | -8 | 7 | 0 |
30 Jun 16 | 0 | -8 | 7 | 0 |
31 Mar 16 | 1 | -7 | 7 | 0 |
31 Dec 15 | 1 | -5 | 5 | 0 |
30 Sep 15 | 1 | -5 | 5 | 0 |
30 Jun 15 | 1 | -5 | 5 | 0 |
31 Mar 15 | 1 | -5 | 6 | 0 |
31 Dec 14 | 1 | -7 | 7 | 0 |
30 Sep 14 | 1 | -7 | 7 | 0 |
30 Jun 14 | 1 | -9 | 9 | 0 |
31 Mar 14 | 0 | -9 | 9 | 0 |
31 Dec 13 | 0 | -9 | 9 | 0 |
30 Sep 13 | 0 | -9 | 8 | 0 |
30 Jun 13 | 0 | -8 | 8 | 0 |
31 Mar 13 | 0 | -9 | 9 | 0 |
31 Dec 12 | 0 | -7 | 7 | 0 |
30 Sep 12 | 0 | -9 | 8 | 0 |
Quality Earnings: S1K is currently unprofitable.
Growing Profit Margin: S1K is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: S1K is unprofitable, and losses have increased over the past 5 years at a rate of 22.4% per year.
Accelerating Growth: Unable to compare S1K's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: S1K is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: S1K has a negative Return on Equity (-138.99%), as it is currently unprofitable.